Fetal alcohol syndrome is defined as a collection of ethanol-induced human neonatal malformations, predominantly of the central nervous system and neural crest, that are the result of excessive maternal ethanol consumption. This syndrome is a leading cause of mental retardation, justifying efforts to understand the teratogenic mechanism in detail. Despite numerous studies designed to analyze ethanol embryotoxicity in humans, rodents, and other vertebrates, no single underlying mechanism for the teratogenic action of ethanol has been widely accepted. A hypothetical mechanism for fetal alcohol syndrome involving an ethanol-induced retinoic acid deficiency has been proposed by this laboratory and will be tested in this proposal. Retinoic acid is the active metabolite of vitamin A and plays a central role in embryonic development as a regulator of gene expression, particularly of-he homeobox gene family which plays a key role in patterning the central nervous system. Since the conversion of retinol (vitamin A alcohol) to retinoic acid by alcohol dehydrogenase is known to be inhibited by ethanol in vitro, it is of great interest to determine if ethanol can effect retinoic acid levels in vivo as well as effect expression of genes known to be regulated by retinoic acid. The similarities between ethanol teratogenesis and retinoid teratogenesis further implicate ethanol as an agent which disturbs retinoic acid levels. Excessive retinoic acid taken during pregnancy is teratogenic to the human fetus, with neonates exhibiting defects similar to those observed for ethanol teratogenesis. Thus, human embryos will undergo normal morphogenesis when converting a small amount of maternally-derived vitamin A (retinol) into retinoic acid in a tissue-specific fashion, but may undergo teratogenesis when responding to events which increase or decrease retinoic acid levels out of the normal range. Goals for this proposal are as follows: (l) Study the effect of various timed doses of prenatal ethanol on retinoid levels in the mouse embryo using HPLC technology to analyze retinoid levels in isolated tissues biochemically, and using a lacZ-retinoic acid indicator cell line to monitor retinoic acid levels in embryo tissues biologically; (2) Analyze by Northern blotting and in situ hybridization the effect of ethanol dose (and timing of dose) on the expression of known retinoic acid target genes in the mouse embryo. The genes studied will include those encoding the homeobox family, the retinoic acid receptor, the cellular retinoic acid binding protein, the cellular retinol binding protein, and various retinoid-metabolizing enzymes including alcohol dehydrogenase, aldehyde dehydrogenase, and cytochrome P450; (3) Examine the in vivo role of alcohol dehydrogenase (ADH) in retinoic acid synthesis by producing ADH mutations in transgenic mice. Three ADH genes have been characterized in the mouse (Adh-1, Adh-2, and Adh-3), and we plan to prepare null mutations in each gene. These knockout mice will be analyzed to determine if loss of a particular ADH results in a change in embryonic development, retinoic acid synthesis, or retinoic acid target gene expression.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
1R01AA009731-01A2
Application #
2045988
Study Section
Biochemistry, Physiology and Medicine Subcommittee (ALCB)
Project Start
1995-04-01
Project End
1998-03-31
Budget Start
1995-04-01
Budget End
1996-03-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
009214214
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Collins, Xixuan H; Harmon, Shawn D; Kaduce, Terry L et al. (2005) Omega-oxidation of 20-hydroxyeicosatetraenoic acid (20-HETE) in cerebral microvascular smooth muscle and endothelium by alcohol dehydrogenase 4. J Biol Chem 280:33157-64
Molotkov, Andrei; Ghyselinck, Norbert B; Chambon, Pierre et al. (2004) Opposing actions of cellular retinol-binding protein and alcohol dehydrogenase control the balance between retinol storage and degradation. Biochem J 383:295-302
Galter, Dagmar; Carmine, Andrea; Buervenich, Silvia et al. (2003) Distribution of class I, III and IV alcohol dehydrogenase mRNAs in the adult rat, mouse and human brain. Eur J Biochem 270:1316-26
Vaglenova, Julia; Martinez, Susana E; Porte, Sergio et al. (2003) Expression, localization and potential physiological significance of alcohol dehydrogenase in the gastrointestinal tract. Eur J Biochem 270:2652-62
Duester, Gregg; Mic, Felix A; Molotkov, Andrei (2003) Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid. Chem Biol Interact 143-144:201-10
Molotkov, Andrei; Fan, Xiaohong; Deltour, Louise et al. (2002) Stimulation of retinoic acid production and growth by ubiquitously expressed alcohol dehydrogenase Adh3. Proc Natl Acad Sci U S A 99:5337-42
Molotkov, Andrei; Fan, Xiaohong; Duester, Gregg (2002) Excessive vitamin A toxicity in mice genetically deficient in either alcohol dehydrogenase Adh1 or Adh3. Eur J Biochem 269:2607-12
Chou, Chu-Fang; Lai, Ching-Long; Chang, Yen-Chun et al. (2002) Kinetic mechanism of human class IV alcohol dehydrogenase functioning as retinol dehydrogenase. J Biol Chem 277:25209-16
Molotkov, Andrei; Duester, Gregg (2002) Retinol/ethanol drug interaction during acute alcohol intoxication in mice involves inhibition of retinol metabolism to retinoic acid by alcohol dehydrogenase. J Biol Chem 277:22553-7
Molotkov, Andrei; Deltour, Louise; Foglio, Mario H et al. (2002) Distinct retinoid metabolic functions for alcohol dehydrogenase genes Adh1 and Adh4 in protection against vitamin A toxicity or deficiency revealed in double null mutant mice. J Biol Chem 277:13804-11

Showing the most recent 10 out of 29 publications